• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴黎分类系统在尿液细胞学检查中用于非肌层浸润性膀胱癌诊断的应用:一项回顾性单中心研究。

The usage of the paris classification system in urine cytology in the diagnosis of non-muscle-invasive bladder cancer: a retrospective single-center study.

作者信息

Saarinen Perttu, Jokelainen Otto, Ruotsalainen Liida, Ikonen Essi, Nykopp Timo K

机构信息

Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.

出版信息

Discov Oncol. 2025 Jan 27;16(1):95. doi: 10.1007/s12672-025-01828-5.

DOI:10.1007/s12672-025-01828-5
PMID:39870906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11772899/
Abstract

PURPOSE

This retrospective single-center study aimed to determine the correlation between The Paris System (TPS) urine cytology classification, cystoscopy findings, and non-muscle-invasive bladder cancer diagnosis. In addition, we sought to identify factors that might explain the abnormal cytology classification in cases in which no malignancy was detected.

METHODS

A Total of 855 patients evaluated with urine cytology between 2017 and 2020 at Kuopio University Hospital were included. Histological diagnoses and urinalysis results were correlated with cytology (TPS). Chi-squared and Fisher's exact tests were used to calculate statistical significance.

RESULTS

In the absence of exophytic tumors on cystoscopy, the risks of bladder cancer was 0.1% for NHGUC, 1.5% for AUC, 22.7% for SHGUC, and 83.3% for HGUC. Positive urinalysis corresponded to lower cytological diagnostic categories in both males and females. A statistically significant difference was observed in males with respect to moderate pyuria, hematuria, and higher cytological categories.

CONCLUSIONS

This study provides evidence that a biopsy or follow-up may not be necessary for patients without a prior history of urothelial carcinoma and without exophytic tumors observed on cystoscopy, when the cytological diagnosis is NHGUC or AUC. Furthermore, concurrent hematuria and pyuria may result in a higher cytological classification.

摘要

目的

本回顾性单中心研究旨在确定巴黎系统(TPS)尿液细胞学分类、膀胱镜检查结果与非肌层浸润性膀胱癌诊断之间的相关性。此外,我们试图找出在未检测到恶性肿瘤的病例中可能解释细胞学分类异常的因素。

方法

纳入2017年至2020年在库奥皮奥大学医院接受尿液细胞学检查的855例患者。组织学诊断和尿液分析结果与细胞学(TPS)相关。采用卡方检验和费舍尔精确检验计算统计学意义。

结果

膀胱镜检查未发现外生性肿瘤时,NHGUC患者患膀胱癌的风险为0.1%,AUC患者为1.5%,SHGUC患者为22.7%,HGUC患者为83.3%。尿液分析阳性在男性和女性中均对应较低的细胞学诊断类别。在男性中,中度脓尿、血尿和较高的细胞学类别存在统计学显著差异。

结论

本研究提供的证据表明,对于无尿路上皮癌既往史且膀胱镜检查未发现外生性肿瘤、细胞学诊断为NHGUC或AUC的患者,可能无需进行活检或随访。此外,同时出现血尿和脓尿可能导致更高的细胞学分类。

相似文献

1
The usage of the paris classification system in urine cytology in the diagnosis of non-muscle-invasive bladder cancer: a retrospective single-center study.巴黎分类系统在尿液细胞学检查中用于非肌层浸润性膀胱癌诊断的应用:一项回顾性单中心研究。
Discov Oncol. 2025 Jan 27;16(1):95. doi: 10.1007/s12672-025-01828-5.
2
Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.巴林地区尿液细胞学检查中巴黎系统对高级别尿路上皮癌筛查的应用价值
Cureus. 2024 Mar 29;16(3):e57189. doi: 10.7759/cureus.57189. eCollection 2024 Mar.
3
Methylation study of the Paris system for reporting urinary (TPS) categories.巴黎系统报告尿路上皮肿瘤(TPS)分类的甲基化研究。
J Clin Pathol. 2021 Feb;74(2):102-105. doi: 10.1136/jclinpath-2020-206633. Epub 2020 Jun 11.
4
Impact of implementing the first edition of the Paris system for reporting: A systematic review and meta-analysis.实施巴黎报告系统第一版的影响:系统评价和荟萃分析。
Cytopathology. 2024 Sep;35(5):616-633. doi: 10.1111/cyt.13407. Epub 2024 Jun 27.
5
Evaluation of a Cytology-Molecular Co-Test in Liquid-Based Cytology-Processed Urine for Defining Indeterminate Categories of the Paris System.评估液基细胞学处理尿液中的细胞学-分子联合检测,以界定巴黎系统的不确定类别。
Acta Cytol. 2024;68(6):532-543. doi: 10.1159/000541578. Epub 2024 Sep 23.
6
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?非肌层浸润性膀胱癌随访中联合细胞学/Epichek 检测:有效工具还是无谓花费?
Urol Oncol. 2021 Feb;39(2):131.e17-131.e21. doi: 10.1016/j.urolonc.2020.06.018. Epub 2020 Aug 7.
7
Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.上尿路标本的细胞学评估:采用第二代巴黎尿细胞学报告系统(附组织病理学随访)的机构回顾性研究。
Cytopathology. 2024 Mar;35(2):235-241. doi: 10.1111/cyt.13328. Epub 2023 Nov 2.
8
[A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].[巴黎系统在肿瘤医院尿细胞学报告中的临床应用的真实世界研究]
Zhonghua Zhong Liu Za Zhi. 2024 Jul 23;46(7):703-709. doi: 10.3760/cma.j.cn112152-20230731-00049.
9
Evaluation of Diagnostic Accuracy of the Paris System (TPS 2.0) in Urine Cytology Specimens: An Institutional Experience From a Large Cohort of a Tertiary Care Centre.巴黎系统(TPS 2.0)在尿液细胞学标本中的诊断准确性评估:来自一家大型三级医疗中心大量队列的机构经验。
Cytopathology. 2025 Mar;36(2):140-149. doi: 10.1111/cyt.13458. Epub 2024 Nov 19.
10
The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.巴黎系统在日常实践中报告尿细胞学,重点是通过多探针 FISH 进行辅助检测。
J Clin Pathol. 2020 Feb;73(2):90-95. doi: 10.1136/jclinpath-2019-206109. Epub 2019 Aug 29.

本文引用的文献

1
Atypical urothelial cells classified according to the Paris System for Reporting Urinary Cytology: A 2-year experience with histological correlation from a Finnish tertiary care center-low rate and high risk of malignancy.根据巴黎泌尿系统细胞学报告系统分类的非典型尿路上皮细胞:来自芬兰三级护理中心的 2 年组织学相关性经验-低检出率和高恶性风险。
Cancer Cytopathol. 2023 Sep;131(9):574-580. doi: 10.1002/cncy.22726. Epub 2023 May 28.
2
The Paris System for Reporting Urinary Cytology: A Meta-Analysis.《巴黎泌尿系统细胞学报告系统:一项荟萃分析》
J Pers Med. 2022 Jan 27;12(2):170. doi: 10.3390/jpm12020170.
3
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).欧洲泌尿外科学会非肌层浸润性膀胱癌(Ta、T1和原位癌)指南
Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10.
4
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
5
Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.《巴黎系统在尿路上皮细胞病理报告中的应用经验:文献复习》
J Am Soc Cytopathol. 2021 Jan-Feb;10(1):79-87. doi: 10.1016/j.jasc.2020.10.002. Epub 2020 Oct 10.
6
Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.尿路上皮细胞学:细胞学-组织病理学与巴黎系统的相关性,一项机构研究。
J Am Soc Cytopathol. 2021 Jan-Feb;10(1):56-63. doi: 10.1016/j.jasc.2020.09.013. Epub 2020 Oct 10.
7
Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement.巴黎尿液细胞病理学报告系统对可疑诊断类别的预测价值及观察者间一致性的影响
Cytojournal. 2019 Oct 22;16:21. doi: 10.4103/cytojournal.cytojournal_30_19. eCollection 2019.
8
Progress towards a Nordic standard for the investigation of hematuria: 2019.血尿调查北欧标准的进展:2019年。
Scand J Urol. 2019 Feb;53(1):1-6. doi: 10.1080/21681805.2018.1555187. Epub 2019 Jan 14.
9
Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guérin (BCG) treatment.尿细胞学是评估卡介苗(BCG)治疗后红斑性膀胱病变的一种可行工具。
BJU Int. 2019 Feb;123(2):246-251. doi: 10.1111/bju.14470. Epub 2018 Aug 12.
10
Red patches during bladder cancer surveillance: to biopsy or not to biopsy?膀胱癌监测期间出现的红色斑块:活检还是不活检?
Transl Androl Urol. 2018 Apr;7(2):280-282. doi: 10.21037/tau.2018.03.10.